C50.91 Kategorie · weitere Spezifizierung erforderlich Malignant neoplasm of breast of unspecified site, female
ICD-10-CM C50.91 identifies “Malignant neoplasm of breast of unspecified site, female” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Kapitel 2: Neoplasms
Hinweise zum Code
Keine zusätzlichen Hinweise.
Hinweise übergeordneter Ebenen
C50 · Malignant neoplasm of breast
Includes3
- connective tissue of breast
- Paget's disease of breast
- Paget's disease of nipple
Use additional code1
code to identify estrogen, and other hormones and factors receptor status (Z17.-)
Kapitel 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Spezifischere Codes
C50.911Malignant neoplasm of unspecified site of right female breastAbrechenbarer, spezifischer CodeC50.912Malignant neoplasm of unspecified site of left female breastAbrechenbarer, spezifischer CodeC50.919Malignant neoplasm of unspecified site of unspecified female breastAbrechenbarer, spezifischer CodeVerweise im offiziellen Index
Verweise im offiziellen Index (26)
Adenocarcinoma (7)
- Adenocarcinoma › duct › infiltrating › unspecified site(female)Krankheitsverzeichnis
- Adenocarcinoma › infiltrating duct › unspecified site(female)Krankheitsverzeichnis
- Adenocarcinoma › inflammatory › unspecified site(female)Krankheitsverzeichnis
- Adenocarcinoma › intraductal › noninfiltrating › papillary › with invasion › unspecified site(female)Krankheitsverzeichnis
- Adenocarcinoma › intraductal › papillary › with invasion › unspecified site(female)Krankheitsverzeichnis
- Adenocarcinoma › lobular › unspecified site(female)Krankheitsverzeichnis
- Adenocarcinoma › papillary › intraductal(noninfiltrating) › with invasion › unspecified site(female)Krankheitsverzeichnis
Cancer (1)
- Cancer › breastKrankheitsverzeichnis
Carcinoma-in-situ (2)
- Carcinoma-in-situ › lobular › with › infiltrating duct › breast(female)Krankheitsverzeichnis
- Carcinoma-in-situ › lobular › with › infiltrating duct › unspecified site(female)Krankheitsverzeichnis
Carcinoma(malignant) (15)
- Carcinoma(malignant) › duct(cell) › infiltrating › with lobular carcinoma(in situ) › unspecified site(female)Krankheitsverzeichnis
- Carcinoma(malignant) › duct(cell) › infiltrating › specified site › unspecified site(female)Krankheitsverzeichnis
- Carcinoma(malignant) › ductal › with lobular › unspecified site(female)Krankheitsverzeichnis
- Carcinoma(malignant) › ductular, infiltrating › unspecified site(female)Krankheitsverzeichnis
- Carcinoma(malignant) › infiltrating › duct › with lobular › unspecified site(female)Krankheitsverzeichnis
- Carcinoma(malignant) › infiltrating › duct › unspecified site(female)Krankheitsverzeichnis
- Carcinoma(malignant) › infiltrating › ductular › unspecified site(female)Krankheitsverzeichnis
- Carcinoma(malignant) › infiltrating › lobular › unspecified site(female)Krankheitsverzeichnis
- Carcinoma(malignant) › inflammatory › unspecified site(female)Krankheitsverzeichnis
- Carcinoma(malignant) › intraductal(noninfiltrating) › papillary › with invasion › unspecified site(female)Krankheitsverzeichnis
- Carcinoma(malignant) › lipid-rich(female)Krankheitsverzeichnis
- Carcinoma(malignant) › lobular(infiltrating) › with intraductal › unspecified site(female)Krankheitsverzeichnis
- Carcinoma(malignant) › lobular(infiltrating) › unspecified site(female)Krankheitsverzeichnis
- Carcinoma(malignant) › medullary › with › lymphoid stroma › unspecified site(female)Krankheitsverzeichnis
- Carcinoma(malignant) › papillary › intraductal(noninfiltrating) › with invasion › unspecified site(female)Krankheitsverzeichnis
Disease, diseased (1)
- Disease, diseased › breast › Paget's › female, unspecified sideKrankheitsverzeichnis
Verlauf
Codeverlauf
Letzte erfasste Änderung · FY2025
GeändertUnverändert
FY2025
Gültig ab
- Übergeordnete Hinweise geändert
Malignant neoplasm of breast of unspecified site, female
Kategorie — spezifischeren Code auswählen
CDC/NCHS · FY2025Alle Ausgaben (19)
| Alle Ausgaben | Gültig ab | Codeverlauf |
|---|---|---|
| FY2016 | 2015-10-01 | Erstmals erfasst |
| FY2017 | 2016-10-01 | Keine tabellarische Änderung |
| FY2018 | 2017-10-01 | Keine tabellarische Änderung |
| FY2019 | 2018-10-01 | Keine tabellarische Änderung |
| FY2020 | 2019-10-01 | Keine tabellarische Änderung |
| FY2020 · April | 2020-04-01 | Keine tabellarische Änderung |
| FY2021 | 2020-10-01 | Keine tabellarische Änderung |
| FY2021 · 01-01 | 2021-01-01 | Keine tabellarische Änderung |
| FY2022 | 2021-10-01 | Keine tabellarische Änderung |
| FY2022 · 04-01 | 2022-04-01 | Keine tabellarische Änderung |
| FY2023 | 2022-10-01 | Keine tabellarische Änderung |
| FY2023 · 04-01 | 2023-04-01 | Keine tabellarische Änderung |
| FY2024 | 2023-10-01 | Keine tabellarische Änderung |
| FY2024 · 04-01 | 2024-04-01 | Keine tabellarische Änderung |
| FY2025 | 2024-10-01 | Übergeordnete Hinweise geändert |
| FY2025 · 04-01 | 2025-04-01 | Keine tabellarische Änderung |
| FY2026 | 2025-10-01 | Keine tabellarische Änderung |
| FY2026 · April | 2026-04-01 | Keine tabellarische Änderung |
| FY2027 | 2026-10-01 | Keine tabellarische Änderung |
Entdecken Sie die spezifischeren Codes dieser Kategorie. Die Referenzprüfung bestätigt keine klinische Eignung und garantiert keine Erstattung.